Yuxa 35 Tablets | Cyproterone Acetate 2 mg + Ethinylestradiol 35 mcg | Hormonal Medicine | 21 Tablets

• Combination Hormonal Medicine: Contains Cyproterone Acetate and Ethinylestradiol.
• Cyproterone Acetate 2 mg: Provides anti-androgenic activity.
• Ethinylestradiol 35 mcg: Estrogen component of the combination.
• 21 Tablets per Strip: Supplied as a 1 × 21 blister pack.
• May be prescribed for appropriate women with androgen-related symptoms such as acne and hirsutism.
• Provides contraceptive action when taken correctly according to medical instructions.
• Prescription Medicine: Requires appropriate medical evaluation and supervision.

• Cyproterone Acetate: 2 mg
• Ethinylestradiol: 0.035 mg (35 mcg)
• Dosage Form: Tablet
• Pack Size: 21 Tablets
• Packing: 1 × 21 Blister
• Route: Oral

• Acne Associated With Androgen Excess: May help manage androgen-related acne in appropriate patients.
• Excessive Hair Growth (Hirsutism): May be prescribed for excessive facial or body hair associated with androgen excess.
• Androgen-Related Symptoms: May be used by a doctor for appropriate hormonal symptoms and menstrual irregularities, including in some patients with PCOS.
• Contraceptive Action: Provides contraceptive action when taken correctly.

Important: Yuxa 35 is not a cure for PCOS. It may help manage certain symptoms associated with PCOS in appropriately selected patients.

• Take Yuxa 35 exactly as prescribed by your doctor or gynecologist.
• Take the tablet orally with water.
• Swallow the tablet whole; do not crush or chew.
• Take it at approximately the same time every day.
• Follow the order and schedule shown on the blister pack.
• Do not start, stop or change the treatment schedule without medical advice.
• If you miss a tablet, follow the instructions supplied with the medicine or consult your doctor or pharmacist.

Dosage: As directed by the Physician.

Yuxa 35 is a prescription hormonal medicine and is not suitable for everyone.

Inform your doctor if you have or have had:

• Blood clots or clotting disorders
• Stroke or heart-related disease
• Migraine, particularly migraine with neurological symptoms
• Liver disease
• Unexplained vaginal bleeding
• Certain hormone-sensitive cancers
• Significant cardiovascular risk factors

Estrogen-containing hormonal medicines can increase the risk of blood clots in some users. Individual risk factors should be assessed by a healthcare professional.

Seek urgent medical attention for sudden chest pain, difficulty breathing, coughing blood, sudden swelling or severe pain in one leg, sudden vision changes, sudden weakness or numbness, or a severe or unusual headache.

Smoking can further increase cardiovascular risks associated with estrogen-containing hormonal medicines.

• Nausea
• Headache
• Abdominal discomfort
• Breast pain or tenderness
• Mood changes
• Weight changes
• Spotting or breakthrough bleeding

Persistent, severe or unusual symptoms should be discussed with your doctor.

Pregnancy: Yuxa 35 should not be used during pregnancy. If pregnancy is suspected, contact your doctor before taking further tablets.

Breastfeeding: Consult your doctor before using this medicine while breastfeeding.

Yuxa 35 is NOT an emergency contraceptive pill.

It should not be marketed as a morning-after pill or as a medicine for terminating an existing pregnancy.

It is a prescription hormonal medicine intended for specific medical indications and contraceptive use under appropriate medical supervision.

• Brand: Yuxa 35
• Generic Name: Cyproterone Acetate + Ethinylestradiol
• Cyproterone Acetate: 2 mg
• Ethinylestradiol: 35 mcg (0.035 mg)
• Dosage Form: Tablet
• Pack Size: 21 Tablets
• Packing: 1 × 21 Blister
• Route: Oral
• Category: Prescription Hormonal Medicine
• Primary Uses: Androgen-related symptoms and contraceptive action
• Storage: Store as directed on the product packaging.